1. Homepage
    2. [**] Medical Imaging
    3. [**] Molecular Imaging
    4. [**] Molecular Imaging Clinical Corner
    5. [**] Scientific and Clinical Publications

    [**] Scientific and Clinical Publications

    Explore Siemens Healthineers' scientific and clinical publications, a collection that offers clinical perspectives and scientific insights from nuclear medicine and molecular imaging leaders.
    [**] Fluoroestradiol F 18 – a molecular marker becomes commercially available for PET imaging in metastatic breast cancer

    A new radiopharmaceutical agent was approved by the FDA for use with PET imaging: Fluoroestradiol F 18 (FES). Known in the U.S. as Cerianna™, it is an estrogen analog and the first F-18 PET imaging agent indicated for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.

    Insights
    [**] The use of SPECT/CT in a musculoskeletal Physical Medicine and Rehabilitation practice

    Ethan Colliver, DO, shares his insight and clinical experience using SPECT/CT in the detection and diagnosis process, and why he feels the utilization of nuclear medicine may result in more targeted and effective treatments.

    Insights